The Profile of People with Diabetes Followed Up in the Context of the Care Trajectory Versus the Diabetes Convention
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20,000
- 主要终点
- HbA1c
研究概览
简要总结
In Belgium, various structures and reimbursement programs are in place for managing Type 2 Diabetes Mellitus (T2DM). The Diabetes Care Trajectory is primarily utilized for patients who require a maximum of two insulin injections per day. In contrast, patients needing multiple daily insulin injections are managed under a diabetes convention program.
The Diabetes Care Trajectory has been operational since 2009. However, unlike patients in the diabetes convention program, where the profile and quality of care are regularly audited, there is limited information available regarding the profile and outcomes of patients within the Care Trajectory. This retrospective study aims to compare the profiles, including complications and quality of care, of T2DM patients across both groups.
详细描述
This retrospective study will collect data from T2DM patients enrolled in either the Diabetes Care Trajectory or the diabetes convention program. The data gathered will encompass quality of care, clinical status, complications, and metabolic state.
The profiles of these patient populations will be compared cross-sectionally for each year within the study period (2009-2024). Additionally, a longitudinal analysis will be conducted to examine the evolution of these profiles over the entire study period. Data will be extracted from electronic case records maintained at participating sites across Belgium.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Followed in one of the NexusHealth hospitals in Belgium: https://www.nexuzhealth.com/en/why-nexuzhealth/patients/affiliated-healthcare-institutions
- •Having being diagnosed with type 2 diabetes mellitus
- •Followed in the Diabetes Care Trajectory or in the Diabetes Convention (group B) in Belgium
排除标准
- •no specific exclusion criteria
结局指标
主要结局
HbA1c
时间窗: Yearly for the entire study period (2009 - 2024)
Glycated haemoglobin A1c
次要结局
- Insulin requirements(Yearly for the entire study period (2009 - 2024))
- Complications of diabetes(Yearly for the entire study period (2009 - 2024))
- Cholesterol profile(Yearly for the entire study period (2009 - 2024))